Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 85 | 2024 | 9791 | 4.620 |
Why?
|
Coronary Disease | 55 | 2024 | 5926 | 3.310 |
Why?
|
Postmenopause | 27 | 2024 | 2519 | 2.990 |
Why?
|
Brain Ischemia | 25 | 2020 | 3038 | 2.540 |
Why?
|
Metabolomics | 13 | 2024 | 1675 | 2.150 |
Why?
|
Cardiovascular Diseases | 66 | 2024 | 15638 | 1.870 |
Why?
|
Women's Health | 24 | 2024 | 2079 | 1.820 |
Why?
|
Nurses | 23 | 2024 | 2494 | 1.410 |
Why?
|
Risk Factors | 170 | 2024 | 74915 | 1.380 |
Why?
|
Hypertension, Pregnancy-Induced | 7 | 2023 | 520 | 1.240 |
Why?
|
Magnesium | 5 | 2015 | 816 | 1.230 |
Why?
|
Gonadal Steroid Hormones | 7 | 2018 | 708 | 1.220 |
Why?
|
Diet | 40 | 2024 | 8098 | 1.160 |
Why?
|
Menopause | 8 | 2022 | 1651 | 1.100 |
Why?
|
Prospective Studies | 141 | 2024 | 54914 | 1.100 |
Why?
|
Potassium, Dietary | 3 | 2015 | 103 | 1.050 |
Why?
|
Estrogens | 8 | 2024 | 1531 | 1.020 |
Why?
|
Female | 287 | 2024 | 396943 | 1.010 |
Why?
|
Middle Aged | 229 | 2024 | 223418 | 1.010 |
Why?
|
Sex Hormone-Binding Globulin | 8 | 2024 | 554 | 1.000 |
Why?
|
Life Style | 26 | 2022 | 3929 | 0.990 |
Why?
|
Retinol-Binding Proteins, Plasma | 2 | 2017 | 94 | 0.970 |
Why?
|
Estrogen Replacement Therapy | 11 | 2017 | 1209 | 0.960 |
Why?
|
Menarche | 2 | 2018 | 538 | 0.950 |
Why?
|
Calcium, Dietary | 4 | 2015 | 533 | 0.950 |
Why?
|
Incidence | 68 | 2024 | 21552 | 0.910 |
Why?
|
Case-Control Studies | 49 | 2024 | 22293 | 0.860 |
Why?
|
Estrogen Receptor beta | 3 | 2009 | 172 | 0.860 |
Why?
|
Estradiol | 7 | 2024 | 1949 | 0.820 |
Why?
|
Diet, Mediterranean | 7 | 2024 | 747 | 0.810 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 58 | 0.800 |
Why?
|
Diet, Vegetarian | 2 | 2021 | 181 | 0.780 |
Why?
|
Body Mass Index | 37 | 2022 | 13030 | 0.770 |
Why?
|
Sex Characteristics | 6 | 2023 | 2666 | 0.770 |
Why?
|
Humans | 308 | 2024 | 768451 | 0.750 |
Why?
|
Dairy Products | 7 | 2021 | 490 | 0.740 |
Why?
|
Aged | 125 | 2024 | 171520 | 0.710 |
Why?
|
Hormone Replacement Therapy | 4 | 2020 | 756 | 0.710 |
Why?
|
Proportional Hazards Models | 46 | 2024 | 12561 | 0.700 |
Why?
|
Myocardial Infarction | 31 | 2023 | 11515 | 0.700 |
Why?
|
Diabetes, Gestational | 2 | 2023 | 1259 | 0.690 |
Why?
|
Intracranial Hemorrhages | 4 | 2020 | 815 | 0.680 |
Why?
|
Hypertension | 22 | 2024 | 8611 | 0.670 |
Why?
|
Disaster Medicine | 1 | 2020 | 75 | 0.660 |
Why?
|
Triglycerides | 5 | 2024 | 2465 | 0.660 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2023 | 367 | 0.660 |
Why?
|
Reproductive Health Services | 1 | 2020 | 90 | 0.660 |
Why?
|
Risk | 36 | 2020 | 9642 | 0.660 |
Why?
|
Multivariate Analysis | 34 | 2019 | 12096 | 0.650 |
Why?
|
Obesity | 17 | 2023 | 13065 | 0.650 |
Why?
|
Endometriosis | 6 | 2024 | 873 | 0.650 |
Why?
|
Phosphatidylcholines | 2 | 2018 | 406 | 0.650 |
Why?
|
C-Reactive Protein | 12 | 2018 | 3854 | 0.640 |
Why?
|
United States | 90 | 2024 | 73121 | 0.630 |
Why?
|
Inflammation Mediators | 5 | 2020 | 1892 | 0.620 |
Why?
|
Pre-Eclampsia | 3 | 2023 | 1257 | 0.620 |
Why?
|
Adult | 168 | 2024 | 223542 | 0.620 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2024 | 1041 | 0.600 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2024 | 12242 | 0.600 |
Why?
|
American Heart Association | 7 | 2024 | 1049 | 0.600 |
Why?
|
Testosterone | 6 | 2020 | 2493 | 0.600 |
Why?
|
Fatty Acids, Omega-3 | 7 | 2020 | 1398 | 0.560 |
Why?
|
Polymorphism, Genetic | 9 | 2009 | 4249 | 0.540 |
Why?
|
Premature Birth | 4 | 2023 | 1816 | 0.540 |
Why?
|
Follow-Up Studies | 62 | 2024 | 39430 | 0.540 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 329 | 0.530 |
Why?
|
Estrogen Receptor alpha | 3 | 2017 | 582 | 0.510 |
Why?
|
Longevity | 5 | 2024 | 1077 | 0.500 |
Why?
|
Menopause, Premature | 2 | 2017 | 124 | 0.490 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 621 | 0.490 |
Why?
|
Inflammation | 11 | 2023 | 10865 | 0.470 |
Why?
|
Weight Gain | 5 | 2020 | 2357 | 0.450 |
Why?
|
Migraine Disorders | 4 | 2024 | 1713 | 0.450 |
Why?
|
Emergencies | 1 | 2020 | 1222 | 0.450 |
Why?
|
Pregnancy | 25 | 2024 | 30179 | 0.450 |
Why?
|
Feeding Behavior | 11 | 2021 | 3202 | 0.440 |
Why?
|
Methylamines | 4 | 2024 | 136 | 0.440 |
Why?
|
Gallstones | 3 | 2024 | 285 | 0.430 |
Why?
|
Nuts | 4 | 2020 | 265 | 0.430 |
Why?
|
Cohort Studies | 63 | 2024 | 41797 | 0.420 |
Why?
|
Dietary Fats | 9 | 2024 | 2003 | 0.420 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2013 | 241 | 0.420 |
Why?
|
Myocardial Revascularization | 2 | 2016 | 796 | 0.410 |
Why?
|
Authorship | 1 | 2016 | 287 | 0.410 |
Why?
|
Chromatography, Liquid | 4 | 2024 | 998 | 0.410 |
Why?
|
Vitamin D | 6 | 2020 | 3311 | 0.410 |
Why?
|
Diabetes Mellitus | 11 | 2024 | 5887 | 0.410 |
Why?
|
Dietary Supplements | 7 | 2020 | 3445 | 0.410 |
Why?
|
Risk Reduction Behavior | 7 | 2024 | 1120 | 0.400 |
Why?
|
Intracranial Aneurysm | 1 | 2022 | 1318 | 0.390 |
Why?
|
Cerebrovascular Disorders | 4 | 2012 | 1487 | 0.390 |
Why?
|
Odds Ratio | 16 | 2017 | 9687 | 0.380 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 879 | 0.370 |
Why?
|
Calcifediol | 1 | 2012 | 160 | 0.370 |
Why?
|
Lipids | 9 | 2023 | 3346 | 0.370 |
Why?
|
Longitudinal Studies | 18 | 2024 | 14766 | 0.360 |
Why?
|
Health Status | 5 | 2019 | 4096 | 0.350 |
Why?
|
Antidepressive Agents | 3 | 2011 | 2913 | 0.350 |
Why?
|
Hormones | 3 | 2023 | 870 | 0.350 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2396 | 0.350 |
Why?
|
Uric Acid | 1 | 2016 | 807 | 0.340 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1097 | 0.340 |
Why?
|
Sex Factors | 12 | 2022 | 10647 | 0.330 |
Why?
|
Telomere | 2 | 2014 | 943 | 0.330 |
Why?
|
Ovulation | 2 | 2020 | 181 | 0.330 |
Why?
|
Flavonoids | 1 | 2012 | 447 | 0.310 |
Why?
|
Publishing | 1 | 2016 | 836 | 0.310 |
Why?
|
Hypercholesterolemia | 6 | 2022 | 1142 | 0.300 |
Why?
|
Estrogens, Conjugated (USP) | 4 | 2020 | 277 | 0.300 |
Why?
|
Male | 97 | 2024 | 364781 | 0.300 |
Why?
|
Dietary Carbohydrates | 6 | 2020 | 896 | 0.300 |
Why?
|
Risk Assessment | 28 | 2024 | 24311 | 0.300 |
Why?
|
Depressive Disorder | 2 | 2011 | 3738 | 0.300 |
Why?
|
Leukocytes | 3 | 2014 | 2030 | 0.300 |
Why?
|
Adipose Tissue | 4 | 2015 | 3335 | 0.300 |
Why?
|
Sleep | 4 | 2023 | 4796 | 0.300 |
Why?
|
Death, Sudden, Cardiac | 8 | 2011 | 1568 | 0.290 |
Why?
|
Parity | 4 | 2021 | 939 | 0.280 |
Why?
|
Cross-Sectional Studies | 20 | 2024 | 26351 | 0.280 |
Why?
|
Amino Acids | 3 | 2023 | 1714 | 0.280 |
Why?
|
Metabolome | 4 | 2024 | 1009 | 0.280 |
Why?
|
Alcohol Drinking | 7 | 2014 | 4052 | 0.270 |
Why?
|
Vitamin D Deficiency | 2 | 2017 | 1389 | 0.270 |
Why?
|
Child Abuse | 3 | 2023 | 1092 | 0.270 |
Why?
|
Genotype | 17 | 2019 | 13047 | 0.270 |
Why?
|
Aircraft | 2 | 2024 | 135 | 0.260 |
Why?
|
Dietary Fiber | 6 | 2024 | 767 | 0.260 |
Why?
|
Infertility | 2 | 2022 | 654 | 0.250 |
Why?
|
Cholesterol, HDL | 8 | 2023 | 1820 | 0.250 |
Why?
|
Electronic Health Records | 2 | 2024 | 4877 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 9 | 2018 | 18048 | 0.240 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 518 | 0.240 |
Why?
|
Tandem Mass Spectrometry | 3 | 2024 | 1197 | 0.240 |
Why?
|
Primary Prevention | 2 | 2024 | 1189 | 0.240 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1468 | 0.240 |
Why?
|
Energy Intake | 6 | 2020 | 2141 | 0.230 |
Why?
|
Biomedical Research | 2 | 2020 | 3463 | 0.230 |
Why?
|
Suicide | 1 | 2015 | 1608 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2019 | 1322 | 0.230 |
Why?
|
Breast Neoplasms | 12 | 2020 | 21156 | 0.220 |
Why?
|
Logistic Models | 11 | 2017 | 13324 | 0.220 |
Why?
|
Neoplasms | 10 | 2023 | 22386 | 0.220 |
Why?
|
Noise, Transportation | 1 | 2024 | 60 | 0.220 |
Why?
|
Asphyxia | 1 | 2024 | 60 | 0.220 |
Why?
|
Age Factors | 16 | 2022 | 18478 | 0.220 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2018 | 16029 | 0.220 |
Why?
|
Premenopause | 2 | 2020 | 1039 | 0.220 |
Why?
|
Health Surveys | 9 | 2020 | 4056 | 0.220 |
Why?
|
Linear Models | 8 | 2021 | 5880 | 0.220 |
Why?
|
Aspirin | 6 | 2022 | 3139 | 0.210 |
Why?
|
Haptoglobins | 2 | 2015 | 165 | 0.210 |
Why?
|
Sterilization, Tubal | 1 | 2023 | 78 | 0.210 |
Why?
|
Adiponectin | 3 | 2018 | 1118 | 0.210 |
Why?
|
Contraceptives, Oral | 2 | 2022 | 562 | 0.210 |
Why?
|
Heart Diseases | 4 | 2021 | 2816 | 0.210 |
Why?
|
Vegetables | 5 | 2020 | 1202 | 0.200 |
Why?
|
Neck Injuries | 1 | 2024 | 163 | 0.200 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2023 | 139 | 0.200 |
Why?
|
Pregnancy Outcome | 3 | 2023 | 2959 | 0.200 |
Why?
|
Dehydroepiandrosterone | 2 | 2017 | 259 | 0.200 |
Why?
|
Persea | 1 | 2022 | 17 | 0.200 |
Why?
|
Choline | 1 | 2024 | 518 | 0.200 |
Why?
|
Abdomen | 3 | 2003 | 1136 | 0.200 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 3438 | 0.200 |
Why?
|
Environmental Exposure | 4 | 2024 | 4533 | 0.200 |
Why?
|
Acetaminophen | 3 | 2006 | 556 | 0.200 |
Why?
|
Diet, Carbohydrate-Restricted | 3 | 2023 | 263 | 0.190 |
Why?
|
Cerebral Hemorrhage | 8 | 2017 | 2665 | 0.190 |
Why?
|
Interleukin-6 | 3 | 2018 | 3234 | 0.190 |
Why?
|
Receptors, Androgen | 1 | 2008 | 1084 | 0.190 |
Why?
|
Cause of Death | 8 | 2024 | 3727 | 0.190 |
Why?
|
Fatty Acids | 3 | 2020 | 1818 | 0.190 |
Why?
|
Parabens | 1 | 2022 | 117 | 0.190 |
Why?
|
Time Factors | 21 | 2020 | 40271 | 0.190 |
Why?
|
Double-Blind Method | 7 | 2020 | 12450 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 348 | 0.180 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.180 |
Why?
|
Smoking | 14 | 2024 | 9099 | 0.180 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 11 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2022 | 2279 | 0.180 |
Why?
|
Skull Fractures | 1 | 2022 | 203 | 0.180 |
Why?
|
Genome-Wide Association Study | 9 | 2022 | 12774 | 0.180 |
Why?
|
Facial Injuries | 1 | 2022 | 191 | 0.180 |
Why?
|
Wounds and Injuries | 3 | 2020 | 2518 | 0.180 |
Why?
|
Genetic Variation | 4 | 2017 | 6610 | 0.170 |
Why?
|
Thromboembolism | 1 | 2007 | 1006 | 0.170 |
Why?
|
Haplotypes | 5 | 2009 | 2725 | 0.170 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2019 | 542 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2022 | 253 | 0.170 |
Why?
|
Fats | 1 | 2020 | 99 | 0.170 |
Why?
|
Maternal Mortality | 1 | 2023 | 305 | 0.170 |
Why?
|
Horses | 1 | 2020 | 296 | 0.170 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2020 | 156 | 0.170 |
Why?
|
Leiomyoma | 1 | 2024 | 640 | 0.170 |
Why?
|
Men's Health | 1 | 2020 | 75 | 0.170 |
Why?
|
Exercise | 11 | 2020 | 5940 | 0.170 |
Why?
|
Socioeconomic Factors | 6 | 2020 | 7863 | 0.170 |
Why?
|
Stress, Psychological | 3 | 2024 | 4538 | 0.170 |
Why?
|
Time | 2 | 2020 | 546 | 0.160 |
Why?
|
Food Preferences | 2 | 2020 | 399 | 0.160 |
Why?
|
Fractures, Bone | 2 | 2021 | 2063 | 0.160 |
Why?
|
Depression | 5 | 2020 | 8235 | 0.160 |
Why?
|
Sex Offenses | 1 | 2023 | 357 | 0.160 |
Why?
|
Air Pollution | 3 | 2020 | 2364 | 0.160 |
Why?
|
Lipid Metabolism | 4 | 2024 | 1898 | 0.160 |
Why?
|
Nutrition Assessment | 2 | 2019 | 740 | 0.150 |
Why?
|
Overweight | 2 | 2011 | 2428 | 0.150 |
Why?
|
Milk | 1 | 2021 | 445 | 0.150 |
Why?
|
Gene Frequency | 4 | 2009 | 3615 | 0.150 |
Why?
|
Forecasting | 2 | 2017 | 2950 | 0.150 |
Why?
|
Birth Weight | 2 | 2023 | 2117 | 0.150 |
Why?
|
Placebos | 2 | 2020 | 1668 | 0.150 |
Why?
|
Phenols | 1 | 2022 | 520 | 0.150 |
Why?
|
Genetic Loci | 5 | 2019 | 2630 | 0.150 |
Why?
|
Work Schedule Tolerance | 2 | 2015 | 553 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2001 | 371 | 0.150 |
Why?
|
Sex Distribution | 5 | 2017 | 2286 | 0.150 |
Why?
|
Infertility, Female | 1 | 2024 | 764 | 0.150 |
Why?
|
Mortality | 4 | 2021 | 2917 | 0.150 |
Why?
|
Waist-Hip Ratio | 3 | 2015 | 520 | 0.150 |
Why?
|
Kentucky | 1 | 2017 | 84 | 0.140 |
Why?
|
Vitamin E | 2 | 2012 | 873 | 0.140 |
Why?
|
Hyperinsulinism | 1 | 2020 | 401 | 0.140 |
Why?
|
Blood Pressure | 5 | 2019 | 8538 | 0.140 |
Why?
|
Nutrition Policy | 1 | 2021 | 467 | 0.140 |
Why?
|
Aged, 80 and over | 21 | 2023 | 59680 | 0.140 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1318 | 0.140 |
Why?
|
Gravidity | 1 | 2017 | 50 | 0.140 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 257 | 0.140 |
Why?
|
Fruit | 4 | 2016 | 1165 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2015 | 10784 | 0.140 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2024 | 4636 | 0.140 |
Why?
|
Nutritive Value | 1 | 2020 | 349 | 0.140 |
Why?
|
Cholesterol | 3 | 2022 | 2910 | 0.140 |
Why?
|
Survivors | 3 | 2017 | 2381 | 0.140 |
Why?
|
Prehypertension | 1 | 2017 | 63 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 280 | 0.140 |
Why?
|
Erythrocytes | 4 | 2020 | 2422 | 0.140 |
Why?
|
Intracranial Thrombosis | 1 | 2017 | 108 | 0.130 |
Why?
|
Vitamin D-Binding Protein | 1 | 2017 | 130 | 0.130 |
Why?
|
Purines | 1 | 2020 | 614 | 0.130 |
Why?
|
Dyslipidemias | 2 | 2021 | 874 | 0.130 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6551 | 0.130 |
Why?
|
Leukoencephalopathies | 1 | 2019 | 261 | 0.130 |
Why?
|
Prognosis | 10 | 2020 | 30028 | 0.130 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15460 | 0.130 |
Why?
|
Intracranial Embolism | 1 | 2017 | 190 | 0.130 |
Why?
|
Workload | 1 | 2022 | 852 | 0.130 |
Why?
|
Sodium Chloride, Dietary | 2 | 2009 | 295 | 0.130 |
Why?
|
Food | 1 | 2020 | 770 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2001 | 809 | 0.120 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 344 | 0.120 |
Why?
|
Specialization | 1 | 2020 | 782 | 0.120 |
Why?
|
Blood Pressure Determination | 2 | 2017 | 646 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 939 | 0.120 |
Why?
|
Comorbidity | 7 | 2024 | 10601 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 2 | 2017 | 797 | 0.120 |
Why?
|
Glutamine | 1 | 2018 | 578 | 0.120 |
Why?
|
Diet Surveys | 6 | 2021 | 1161 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 577 | 0.120 |
Why?
|
Seafood | 3 | 2003 | 395 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2016 | 1133 | 0.120 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2015 | 224 | 0.110 |
Why?
|
Physicians, Women | 1 | 2020 | 519 | 0.110 |
Why?
|
Cyclohexanols | 1 | 2014 | 126 | 0.110 |
Why?
|
Parenting | 1 | 2020 | 707 | 0.110 |
Why?
|
Rural Health | 1 | 2015 | 300 | 0.110 |
Why?
|
Climate Change | 1 | 2020 | 510 | 0.110 |
Why?
|
Abdominal Fat | 3 | 2015 | 221 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1095 | 0.110 |
Why?
|
Dietary Proteins | 3 | 2011 | 960 | 0.110 |
Why?
|
Trace Elements | 1 | 2015 | 193 | 0.110 |
Why?
|
Drug Utilization | 1 | 2019 | 1192 | 0.110 |
Why?
|
Obstetrics | 1 | 2020 | 676 | 0.110 |
Why?
|
Carbonated Beverages | 2 | 2012 | 210 | 0.110 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 202 | 0.110 |
Why?
|
Republic of Korea | 1 | 2015 | 587 | 0.110 |
Why?
|
Progesterone | 1 | 2017 | 750 | 0.110 |
Why?
|
Fasting | 2 | 2017 | 1608 | 0.110 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5162 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 838 | 0.110 |
Why?
|
Diabetic Angiopathies | 3 | 2009 | 806 | 0.100 |
Why?
|
Coffee | 2 | 2009 | 598 | 0.100 |
Why?
|
Urban Health | 1 | 2015 | 535 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2015 | 433 | 0.100 |
Why?
|
Nutritional Status | 1 | 2021 | 1623 | 0.100 |
Why?
|
ROC Curve | 2 | 2018 | 3624 | 0.100 |
Why?
|
Lactation | 2 | 2020 | 397 | 0.100 |
Why?
|
Fibrinogen | 1 | 2016 | 892 | 0.100 |
Why?
|
Kidney | 3 | 2004 | 7064 | 0.100 |
Why?
|
Databases, Nucleic Acid | 1 | 2013 | 204 | 0.100 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 552 | 0.100 |
Why?
|
Anthropometry | 3 | 2003 | 1343 | 0.100 |
Why?
|
Hyperglycemia | 2 | 2020 | 1389 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 983 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3440 | 0.100 |
Why?
|
Breast | 2 | 2012 | 1976 | 0.100 |
Why?
|
United States Department of Agriculture | 1 | 2012 | 47 | 0.100 |
Why?
|
Glutamic Acid | 1 | 2018 | 1192 | 0.100 |
Why?
|
Aromatase | 1 | 2012 | 147 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2024 | 81834 | 0.100 |
Why?
|
Citrus | 1 | 2012 | 50 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 946 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3826 | 0.100 |
Why?
|
Constipation | 1 | 2016 | 570 | 0.100 |
Why?
|
Health Status Indicators | 2 | 2014 | 971 | 0.090 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.090 |
Why?
|
Alleles | 4 | 2012 | 6890 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2433 | 0.090 |
Why?
|
Bereavement | 1 | 2015 | 310 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3629 | 0.090 |
Why?
|
Particulate Matter | 2 | 2020 | 2614 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1134 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8051 | 0.090 |
Why?
|
Androgens | 2 | 2009 | 1285 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7471 | 0.090 |
Why?
|
Life Expectancy | 1 | 2018 | 1249 | 0.090 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.090 |
Why?
|
Dietary Sucrose | 2 | 2012 | 243 | 0.090 |
Why?
|
Aging | 3 | 2018 | 8761 | 0.090 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1804 | 0.090 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 415 | 0.090 |
Why?
|
Motor Activity | 4 | 2011 | 2722 | 0.090 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 127 | 0.090 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2014 | 277 | 0.090 |
Why?
|
Reference Values | 3 | 2017 | 4941 | 0.090 |
Why?
|
Smoking Cessation | 2 | 2020 | 2079 | 0.090 |
Why?
|
Meat | 3 | 2011 | 586 | 0.090 |
Why?
|
Young Adult | 12 | 2024 | 60045 | 0.090 |
Why?
|
Reference Standards | 1 | 2013 | 1015 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1255 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2014 | 568 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2362 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1320 | 0.080 |
Why?
|
Child Abuse, Sexual | 1 | 2012 | 404 | 0.080 |
Why?
|
Sunlight | 1 | 2011 | 337 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1884 | 0.080 |
Why?
|
Adolescent | 13 | 2024 | 89168 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2017 | 1836 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1207 | 0.080 |
Why?
|
Iron | 2 | 2008 | 1813 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3145 | 0.080 |
Why?
|
Quality Improvement | 1 | 2024 | 3858 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1638 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4421 | 0.080 |
Why?
|
Health Behavior | 4 | 2019 | 2649 | 0.080 |
Why?
|
Hysterectomy | 2 | 2024 | 863 | 0.080 |
Why?
|
Vehicle Emissions | 1 | 2013 | 656 | 0.080 |
Why?
|
Drinking Behavior | 1 | 2009 | 103 | 0.080 |
Why?
|
Antioxidants | 1 | 1996 | 1678 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2015 | 2119 | 0.080 |
Why?
|
Glycemic Index | 2 | 2008 | 400 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2014 | 1479 | 0.070 |
Why?
|
Pregnancy Proteins | 1 | 2008 | 224 | 0.070 |
Why?
|
Pyrimidines | 1 | 2020 | 3050 | 0.070 |
Why?
|
Infant, Newborn | 7 | 2023 | 26395 | 0.070 |
Why?
|
Galectin 2 | 1 | 2007 | 13 | 0.070 |
Why?
|
Massachusetts | 4 | 2023 | 8908 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1395 | 0.070 |
Why?
|
Lymphotoxin-alpha | 1 | 2007 | 94 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2007 | 151 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3672 | 0.070 |
Why?
|
Complement Factor H | 1 | 2007 | 110 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2012 | 557 | 0.070 |
Why?
|
Physical Fitness | 2 | 2001 | 744 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4362 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2009 | 489 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2011 | 1724 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36840 | 0.070 |
Why?
|
Societies, Medical | 2 | 2020 | 3955 | 0.070 |
Why?
|
Animals | 9 | 2023 | 169418 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2601 | 0.060 |
Why?
|
Body Composition | 1 | 2015 | 2455 | 0.060 |
Why?
|
PPAR gamma | 2 | 2007 | 487 | 0.060 |
Why?
|
Trans Fatty Acids | 1 | 2007 | 155 | 0.060 |
Why?
|
Down-Regulation | 1 | 2013 | 2944 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 784 | 0.060 |
Why?
|
Glucose | 2 | 2008 | 4355 | 0.060 |
Why?
|
Calcium | 2 | 2014 | 5793 | 0.060 |
Why?
|
Epidemiologic Methods | 3 | 2019 | 1337 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 935 | 0.060 |
Why?
|
Pentanoic Acids | 1 | 2024 | 19 | 0.060 |
Why?
|
C-Peptide | 2 | 2020 | 444 | 0.060 |
Why?
|
Mammography | 3 | 2014 | 2436 | 0.060 |
Why?
|
Primary Health Care | 1 | 2022 | 4737 | 0.060 |
Why?
|
Estriol | 1 | 2024 | 54 | 0.060 |
Why?
|
Progestins | 1 | 2007 | 302 | 0.060 |
Why?
|
Vitamin K 1 | 1 | 2005 | 47 | 0.060 |
Why?
|
Prevalence | 8 | 2018 | 15880 | 0.060 |
Why?
|
Heme | 1 | 2007 | 316 | 0.060 |
Why?
|
Creatinine | 4 | 2004 | 1915 | 0.060 |
Why?
|
Family | 1 | 2015 | 3208 | 0.060 |
Why?
|
Coronary Artery Bypass | 2 | 2011 | 2194 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7956 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2020 | 10358 | 0.060 |
Why?
|
Probability | 4 | 2018 | 2483 | 0.060 |
Why?
|
Colorectal Neoplasms | 3 | 2012 | 6978 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 947 | 0.060 |
Why?
|
Beverages | 1 | 2009 | 822 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 490 | 0.050 |
Why?
|
Physical Exertion | 1 | 2006 | 669 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6429 | 0.050 |
Why?
|
Nucleosides | 1 | 2023 | 131 | 0.050 |
Why?
|
Circadian Rhythm | 2 | 2017 | 2585 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2018 | 1998 | 0.050 |
Why?
|
Body Height | 1 | 2009 | 1568 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5510 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15965 | 0.050 |
Why?
|
DNA | 3 | 2023 | 7213 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2005 | 441 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 655 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1415 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7451 | 0.050 |
Why?
|
Airports | 1 | 2021 | 31 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3237 | 0.050 |
Why?
|
China | 2 | 2017 | 2398 | 0.050 |
Why?
|
Lactase | 1 | 2021 | 72 | 0.050 |
Why?
|
Carcinoma | 1 | 2012 | 2341 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3123 | 0.050 |
Why?
|
Ovarian Follicle | 1 | 2022 | 244 | 0.050 |
Why?
|
Patient Compliance | 1 | 2011 | 2696 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2754 | 0.050 |
Why?
|
Ovariectomy | 1 | 2023 | 614 | 0.050 |
Why?
|
Kynurenine | 1 | 2021 | 142 | 0.040 |
Why?
|
Folic Acid | 2 | 2005 | 1336 | 0.040 |
Why?
|
Carnitine | 1 | 2021 | 254 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2022 | 726 | 0.040 |
Why?
|
Breast Feeding | 1 | 2008 | 1365 | 0.040 |
Why?
|
Self Report | 3 | 2020 | 3771 | 0.040 |
Why?
|
Analgesics | 2 | 2006 | 1070 | 0.040 |
Why?
|
Quality of Life | 1 | 2002 | 13497 | 0.040 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2028 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20231 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5952 | 0.040 |
Why?
|
Corneal Diseases | 1 | 2005 | 539 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4120 | 0.040 |
Why?
|
Insulin Resistance | 2 | 2015 | 3974 | 0.040 |
Why?
|
Regression Analysis | 3 | 2008 | 6353 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5827 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 772 | 0.040 |
Why?
|
Tryptophan | 1 | 2021 | 483 | 0.040 |
Why?
|
Child Care | 1 | 2020 | 126 | 0.040 |
Why?
|
Parental Leave | 1 | 2020 | 92 | 0.040 |
Why?
|
Mothers | 2 | 2020 | 2210 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2022 | 542 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2019 | 2358 | 0.040 |
Why?
|
Diet Records | 2 | 2014 | 427 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 305 | 0.040 |
Why?
|
Fabaceae | 2 | 2011 | 104 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 240 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7066 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 473 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 267 | 0.030 |
Why?
|
Mass Screening | 2 | 2024 | 5455 | 0.030 |
Why?
|
Child | 7 | 2023 | 80863 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2020 | 1053 | 0.030 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2017 | 139 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5803 | 0.030 |
Why?
|
Awards and Prizes | 1 | 2020 | 365 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1422 | 0.030 |
Why?
|
Upper Extremity | 1 | 2021 | 682 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10845 | 0.030 |
Why?
|
Fishes | 2 | 2011 | 605 | 0.030 |
Why?
|
Potassium | 1 | 1999 | 1319 | 0.030 |
Why?
|
Up-Regulation | 2 | 2015 | 4138 | 0.030 |
Why?
|
Genetic Testing | 1 | 2008 | 3586 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1575 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1146 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 557 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2011 | 2932 | 0.030 |
Why?
|
Career Choice | 1 | 2020 | 769 | 0.030 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2014 | 190 | 0.030 |
Why?
|
Mice | 1 | 2020 | 82045 | 0.030 |
Why?
|
Politics | 1 | 2020 | 821 | 0.030 |
Why?
|
Insulin | 2 | 2021 | 6606 | 0.030 |
Why?
|
Survival Rate | 3 | 2016 | 12875 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 705 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2399 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 681 | 0.030 |
Why?
|
Saliva | 1 | 2017 | 854 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1364 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2102 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3439 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 1996 | 579 | 0.020 |
Why?
|
Paternal Age | 1 | 2012 | 87 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7895 | 0.020 |
Why?
|
Food Handling | 1 | 2011 | 158 | 0.020 |
Why?
|
Eating | 2 | 2011 | 1538 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4816 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1750 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8730 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1395 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1604 | 0.020 |
Why?
|
Eggs | 1 | 2011 | 182 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 479 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2268 | 0.020 |
Why?
|
Chemoprevention | 1 | 2012 | 326 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2226 | 0.020 |
Why?
|
Wakefulness | 1 | 2017 | 1280 | 0.020 |
Why?
|
Health Occupations | 1 | 2011 | 225 | 0.020 |
Why?
|
Glycosylation | 1 | 2013 | 1100 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2015 | 1036 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2012 | 290 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3596 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1755 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4622 | 0.020 |
Why?
|
Molecular Weight | 1 | 2011 | 2173 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 738 | 0.020 |
Why?
|
Age Distribution | 2 | 2007 | 2881 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42623 | 0.020 |
Why?
|
Iron, Dietary | 1 | 2008 | 149 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2411 | 0.020 |
Why?
|
Walking | 2 | 2008 | 1202 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3543 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1999 | 2768 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 300 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10125 | 0.020 |
Why?
|
Urinalysis | 1 | 2009 | 369 | 0.020 |
Why?
|
Iron Overload | 1 | 2008 | 241 | 0.020 |
Why?
|
Body Weight | 1 | 1997 | 4630 | 0.020 |
Why?
|
Morbidity | 1 | 2011 | 1760 | 0.020 |
Why?
|
Cattle | 1 | 2011 | 3830 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3922 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3546 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 993 | 0.020 |
Why?
|
Ferritins | 1 | 2008 | 601 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3384 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2008 | 1181 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3342 | 0.020 |
Why?
|
Chromium Compounds | 1 | 2004 | 7 | 0.010 |
Why?
|
Plasma | 1 | 2008 | 588 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2006 | 642 | 0.010 |
Why?
|
Fish Oils | 1 | 2008 | 483 | 0.010 |
Why?
|
Glomerular Filtration Rate | 2 | 2003 | 2226 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2013 | 2146 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 2008 | 563 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 216 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2015 | 3122 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5103 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 321 | 0.010 |
Why?
|
Ethanol | 1 | 2010 | 1334 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1585 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9382 | 0.010 |
Why?
|
Edetic Acid | 1 | 2003 | 278 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 607 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1779 | 0.010 |
Why?
|
Melanoma | 1 | 2000 | 5740 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2705 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3484 | 0.010 |
Why?
|
Swine | 1 | 2011 | 5996 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9425 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2008 | 907 | 0.010 |
Why?
|
Caffeine | 1 | 2006 | 702 | 0.010 |
Why?
|
Chlorides | 1 | 2004 | 663 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 2003 | 681 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1615 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2014 | 65409 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2001 | 224 | 0.010 |
Why?
|
Sunscreening Agents | 1 | 2000 | 139 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14728 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4041 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6242 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8373 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6537 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1643 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36497 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 6217 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2005 | 1734 | 0.010 |
Why?
|
Syndrome | 1 | 2003 | 3278 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16712 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1256 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20762 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2000 | 1100 | 0.010 |
Why?
|
Boston | 1 | 2008 | 9361 | 0.010 |
Why?
|
Medical Records | 1 | 2001 | 1413 | 0.010 |
Why?
|
Physicians | 2 | 2003 | 4615 | 0.010 |
Why?
|
Health Education | 1 | 2000 | 1059 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2003 | 2258 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 2489 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2001 | 2901 | 0.010 |
Why?
|
Heart Failure | 1 | 2013 | 11857 | 0.010 |
Why?
|